Risdiplam – November 2025

• Brand names:
  • Evrysdi®
• Pharmaceutical Company:
  • ROCHE PRODUCTS PTY LTD
• Condition/Indication: Spinal muscular atrophy (SMA)
• Meeting Date: November 2025
• Public Summary Document (PSD) November 2025 PBAC Meeting - (PDF 801.3KB)
• Public Summary Document (PSD) November 2025 PBAC Meeting - (Word 171.8KB)